Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Pancreatic Cancer
Interventions
DEVICE

22 gauge ProCore needle aspiration

Pancreatic mass evaluation through the 22 gauge ProCore needle aspiration

DEVICE

22 gauge Fine needle aspiration

Pancreatic mass evaluation through the 22 gauge Fine needle aspiration

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Olympus

INDUSTRY

lead

Samsung Medical Center

OTHER